Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma
Figure 1
Expression of surface antigens. (a). Flow cytometric phenotyping of all cell lines was done with mABs against LIR-1, CD56, CD16, CNKG2A, CD2, and CD25 as shown for NK-92. (b). Surface antigen expression on NK-92 and tumor cell lines. Values given as % positive staining after subtraction of isotype control.
